New diabetes clinical trial: A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity.

Published on: September 09, 2025 at 11:00PM
Conditions: Uterine Cervical Neoplasm
Interventions: Dietary Supplement: Sodium-copper-chlorophyllin, a semi-synthetic derivative of chlorophyll, is made up of a mixture of sodium copper salts.
Sponsors: Tata Memorial Hospital
Not yet recruiting
https://ift.tt/le7VSA6

Comments